Therapeutic targets in cancer cell metabolism and autophagy

Area of Science:

• Oncology
• Molecular Biology
• Metabolism

Background:

• Cancer cells exhibit altered metabolism driven by oncogene signaling and metabolic enzyme dysregulation.
• This metabolic reprogramming supports tumor cell proliferation and survival, leading to nutrient dependency.
• Metabolic enzymes are recognized as crucial targets for novel cancer therapies.

Purpose of the Study:

• To explore the critical roles of specific metabolic enzyme isoforms and autophagy in tumor cell adaptation to nutrient fluctuations.
• To highlight the therapeutic potential of targeting these adaptive mechanisms in cancer treatment.

Main Methods:

• Review of current literature on cancer metabolism, oncogene signaling, and metabolic enzyme function.
• Analysis of the role of specific enzyme isoforms and autophagy in cancer cell survival and proliferation.
• Examination of existing and experimental therapeutics targeting these pathways.

Main Results:

• Expression of specific metabolic enzyme isoforms and autophagy are vital for cancer cell adaptation to nutrient availability.
• These processes render cancer cells vulnerable to targeted therapeutic interventions.
• A growing number of approved and experimental drugs target these identified pathways.

Conclusions:

• Understanding the molecular underpinnings of cancer-associated metabolic alterations is essential for advancing therapeutic strategies.
• Targeting metabolic enzyme expression and autophagy presents a promising avenue for improved cancer therapies.